ONCY hard to move, SGNL will do much better on good updates imo http://www.dakotafinancialnews.com/zacks-upgrades-signal-genetics-to-buy-sgnl/385184/ As of August 5, 2015, there were 7,868,096 shares of the issuer’s common stock, par value $0.01 per share, outstanding. Solid. $13m assets vs $2m liabilities Cash, end of period $10m Market cap $11.6m